ArticleProbiotics and antimicrobial proteins2026
Antimicrobial Activity and Peptidomic Analysis of Halotolerant Lactiplantibacillus plantarum CH.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
As antibiotic-resistant bacteria emerge, antimicrobial peptides have become a promising alternative due to their safety, low residue, and low resistance properties. This study evaluated the in vitro antibacterial activity of peptides obtained from the fermentation of a halotolerant Lactiplantibacillus plantarum CH. Moreover, an in silico antimicrobial activity of L. plantarum was predicted. The strain was previously isolated from ripened, salty Mexican cheese (Chiapas cheese) and genetically reidentified using 16S rRNA. Antimicrobial activity was assessed in MRS broth against five common food pathogens, and the proteinaceous nature of the active compounds was confirmed. Peptidomic analysis revealed 57 peptides with antimicrobial potential, ranging in molecular weight from 767.88 to 4859.55 Da. Three peptides (NINLQTELIAGVTSFFAISYIIVV, KDPFPFVHTNIIGTYT, and IKVIAGLVVIILAFLIGRILIQGV) demonstrated antimicrobial, antibacterial, antifungal, and antiviral activity. The peptide QSFQDTLPALVKGVILILIAWLVAVLVKNVVTKGFKKIKLD exhibited the highest antibacterial activity. Additionally, ten peptides contributed to the bacterium's probiotic effects, suggesting potential food preservation and health enhancement applications. The physicochemical properties of these peptides were explored to understand their mechanisms of action. However, further research involving synthesizing and testing the most active peptides is necessary to corroborate these findings and fully elucidate their potential as antimicrobial agents.
Indexed as
Identifiers
40069511What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.